Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03898310 · ClinicalTrials.gov registry record · NA
UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery
A NA study of Urinary Tract Infections and Incontinence, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
- 1
- Study location
NCT03898310: Completed NA study of Urinary Tract Infections and Incontinence, sponsored by University of Oklahoma.
NCT03898310 is a NA study of Urinary Tract Infections and Incontinence that has completed, run by University of Oklahoma. The registered enrollment target is 141 participants, below the 454-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03898310, a NA study of Urinary Tract Infections and Incontinence, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
The risk of urinary tract infection (UTI) following female incontinence surgery ranges between 6-48%. The literature has shown mixed results of the therapeutic efficacy of cranberry extract to prevent UTI in females, with some promising preliminary work in the prevention of UTI's following gynecologic surgery. The researchers will conduct a study of the effect of cranberry extracts on preventing urinary tract infections following mid urethral slings, which are the most common urinary incontinence procedures.
Primary Outcome
A urine culture to determine UTI will be performed based on symptoms such as urgency, frequency, dysuria or hematuria following incontinence surgery, as reported by the participant.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo capsule
- DIETARY_SUPPLEMENT Cranberry extract capsules
Study Locations (1)
Oklahoma
- University of Oklahoma - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2019-02-05 |
| Est. Completion | 2023-01-22 |
| Phase | NA |
What the finished NCT03898310 record still lists
NCT03898310 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 454-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (69% lower).
The record links to 2 conditions, with Urinary Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which Placebo capsule is the first listed.
NCT03898310 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT03898310 about?
NCT03898310 is a clinical study titled "UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery". The risk of urinary tract infection (UTI) following female incontinence surgery ranges between 6-48%. The literature has shown mixed results of the therapeutic efficacy of cranberry extract to prevent UTI in females, with some promising preliminary work in the prevention of UTI's following gynecolog...
What is the current status of trial NCT03898310?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2019-02-05. Estimated completion is 2023-01-22.
What conditions does trial NCT03898310 study?
This clinical trial studies the following conditions: Urinary Tract Infections, Incontinence.
What interventions are being tested in trial NCT03898310?
The interventions under investigation include: Placebo capsule (DIETARY_SUPPLEMENT), Cranberry extract capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03898310?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03898310 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03898310's enrollment target sits among peer trials
141 20th of 34 higher than 15 of 34 other Urinary Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Double Voiding and Post-transplant UTI
RECRUITING · NA
-
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
RECRUITING · NA
-
Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI